Bexarotene: A Rare Cause of Misleading Thyroid Function Tests.
bexarotene
central hypothyroidism
cutaneous t-cell lymphoma
mycosis fungoides
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
20 Nov 2020
20 Nov 2020
Historique:
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Bexarotene is a very rare cause of central hypothyroidism (CH) and its effects have been reported to be dose-dependent; however, the available data in the literature on dose-dependent effects are variable. The standard practice of monitoring thyroid function using thyroid-stimulating hormone (TSH) to adjust levothyroxine (LT4) dose does not apply to bexarotene since it causes CH. In CH, TSH is not reliable. Hence free tetraiodothyronine (fT
Identifiants
pubmed: 33364113
doi: 10.7759/cureus.11591
pmc: PMC7752737
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e11591Informations de copyright
Copyright © 2020, Pattan et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Br J Dermatol. 2013 Jan;168(1):192-200
pubmed: 22963233
Mol Cell Endocrinol. 1997 Aug 8;131(2):137-46
pubmed: 9296372
N Engl J Med. 1999 Apr 8;340(14):1075-9
pubmed: 10194237
Clin Endocrinol (Oxf). 2019 Jul;91(1):195-200
pubmed: 30903705
Mol Endocrinol. 1997 Apr;11(4):481-9
pubmed: 9092800
Arch Dermatol. 2001 May;137(5):581-93
pubmed: 11346336
J Clin Oncol. 2001 May 1;19(9):2456-71
pubmed: 11331325
Onco Targets Ther. 2015 Feb 03;8:367-73
pubmed: 25678803